Intervention
Stem-cell therapy
- Works
- 580
- Clinical trials
- 1
- Total citations
- 178,428
- Open access
- 523
Evidence brief
previewSynthesis (preview — no live AI key for the active provider):
Across the retrieved literature, senescent-cell burden and chronic inflammation recur as central, interacting drivers, with intervention studies reporting functional gains in model organisms. Key works: [1][2][3][4][5].
Publication velocity
20002026
Clinical trials
University of Aberdeen 2026
Open access · US-GOV
Regenerative Effects of Young Immortalized and Engineered MSC-Derived EVs on Aging and Senescent Brain Models
Most-cited works
Stem Cells 2006
Citation only
Comparative Analysis of Mesenchymal Stem Cells from Bone Marrow, Umbilical Cord Blood, or Adipose Tissue
Critical Reviews in Biomedical Engineering 2012
Citation only
Bone Tissue Engineering: Recent Advances and Challenges
npj Regenerative Medicine 2019
Open access · CC-BY
Mesenchymal stem cell perspective: cell biology to clinical progress
Journal of Cellular Physiology 2007
Open access · OA
Adult mesenchymal stem cells for tissue engineering versus regenerative medicine
Signal Transduction and Targeted Therapy 2020
Open access · CC-BY
Targeting cancer stem cell pathways for cancer therapy
Stem Cell Research & Therapy 2019
Open access · CC-BY
Stem cells: past, present, and future
Blood 2007
Open access · OA
Immunomodulatory properties of mesenchymal stromal cells
Cell Communication and Signaling 2011
Open access · CC-BY
Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC
Signal Transduction and Targeted Therapy 2022
Open access · CC-BY
Aging and aging-related diseases: from molecular mechanisms to interventions and treatments
Blood 2003
Open access · OA